Adverse Effects Associated with Proton Pump Inhibitor Use

Proton pump inhibitors (PPIs) marked a before and after in the management of gastric acid‐related disorders since their introduction to the market in 1989. Due to a novel, highly effective mechanism of action blocking the last converging step of gastric acid secretion by parietal cells and very few...

Descripción completa

Detalles Bibliográficos
Autores principales: Yibirin, Marcel, De Oliveira, Diana, Valera, Roberto, Plitt, Andrea E, Lutgen, Sophia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887997/
https://www.ncbi.nlm.nih.gov/pubmed/33614352
http://dx.doi.org/10.7759/cureus.12759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887997/
https://www.ncbi.nlm.nih.gov/pubmed/33614352
http://dx.doi.org/10.7759/cureus.12759

Ejemplares similares